Medicines Co. Sues Mylan Over Generic Angiomax
By Ryan Davis ( February 24, 2011, 2:32 PM EST) -- The Medicines Co. filed a patent infringement suit against Mylan Inc. in an Illinois federal court Wednesday in an effort to block the defendant's planned generic version of its anti-coagulant drug Angiomax....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.